August 20, 2014 7:22 AM ET

Biotechnology

Company Overview of AvidBiotics Corp.

Executive Profile

Martin J. Blaser M.D.

Member of Influenza Advisory Board, Adamas Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Martin J. Blaser, MD serves as Scientific & Clinical Advisor of Adamas Pharmaceuticals Inc. Dr. Blaser is a Professor of Microbiology at New York University School of Medicine. He is a Diplomate from American Board of Internal Medicine, subspecialty of Infectious Diseases. He has served as President of the Infectious Diseases Society of America, Chair of the Board of Scientific Counselors of the National Cancer Institute, and is Vice Chair of the Advisory Board for ...

Corporate Headquarters

100 Kimball Way
South San Francisco, California 94080

United States

Phone: 650-873-1234
Fax: 650-873-1010

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD 1973
New York University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AvidBiotics Corp., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.